. A good marker does not mean a good target for clinical trials in Alzheimer's disease: the amyloid hypothesis questioned. Neurodegener Dis Manag. 2019 Jun;9(3):119-121. Epub 2019 May 22 PubMed.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.